Cotiviti Holdings, Inc. (NYSE:COTV) COO David Beaulieu sold 5,000 shares of the business’s stock in a transaction on Wednesday, April 18th. The shares were sold at an average price of $35.00, for a total transaction of $175,000.00. Following the completion of the transaction, the chief operating officer now directly owns 44,425 shares in the company, valued at $1,554,875. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.
David Beaulieu also recently made the following trade(s):
- On Thursday, March 15th, David Beaulieu sold 5,000 shares of Cotiviti stock. The shares were sold at an average price of $36.11, for a total transaction of $180,550.00.
Shares of COTV opened at $34.65 on Monday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.73 and a current ratio of 1.73. The firm has a market capitalization of $3,202.42, a price-to-earnings ratio of 24.40, a PEG ratio of 1.59 and a beta of 0.82. Cotiviti Holdings, Inc. has a 1 year low of $30.84 and a 1 year high of $45.97.
Cotiviti (NYSE:COTV) last posted its quarterly earnings results on Wednesday, February 21st. The business services provider reported $0.47 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.43 by $0.04. Cotiviti had a net margin of 20.36% and a return on equity of 13.29%. The business had revenue of $176.70 million for the quarter, compared to analysts’ expectations of $179.43 million. During the same period in the prior year, the company posted $0.39 EPS. The business’s revenue for the quarter was up 5.2% on a year-over-year basis. equities research analysts expect that Cotiviti Holdings, Inc. will post 1.67 EPS for the current year.
Several equities analysts have issued reports on the stock. Zacks Investment Research raised shares of Cotiviti from a “hold” rating to a “buy” rating and set a $39.00 price objective on the stock in a research note on Wednesday, April 18th. First Analysis cut shares of Cotiviti from an “overweight” rating to an “equal weight” rating and dropped their price objective for the company from $48.00 to $40.00 in a research note on Friday, February 23rd. Finally, Citigroup assumed coverage on shares of Cotiviti in a research note on Thursday, January 4th. They issued a “buy” rating on the stock. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and six have issued a buy rating to the stock. The stock currently has an average rating of “Buy” and an average price target of $40.88.
Large investors have recently bought and sold shares of the company. Tower Research Capital LLC TRC grew its stake in shares of Cotiviti by 81.7% during the 4th quarter. Tower Research Capital LLC TRC now owns 4,100 shares of the business services provider’s stock worth $132,000 after purchasing an additional 1,844 shares during the period. Great West Life Assurance Co. Can grew its stake in shares of Cotiviti by 92.1% during the 3rd quarter. Great West Life Assurance Co. Can now owns 5,570 shares of the business services provider’s stock worth $198,000 after purchasing an additional 2,670 shares during the period. First Quadrant L P CA acquired a new position in shares of Cotiviti during the 4th quarter worth $254,000. Cigna Investments Inc. New acquired a new position in shares of Cotiviti during the 4th quarter worth $264,000. Finally, Jefferies Group LLC acquired a new stake in Cotiviti in the 4th quarter valued at about $283,000. 92.65% of the stock is currently owned by institutional investors and hedge funds.
TRADEMARK VIOLATION NOTICE: This news story was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this news story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright laws. The legal version of this news story can be read at https://www.dispatchtribunal.com/2018/04/23/cotiviti-holdings-inc-cotv-coo-sells-175000-00-in-stock.html.
Cotiviti Company Profile
Cotiviti Holdings, Inc, through its subsidiaries, provides analytics-driven payment accuracy and spend management solutions primarily for the healthcare sector in the United States, Canada, the United Kingdom, and India. It operates through two segments, Healthcare, and Global Retail and Other. The company offers prospective claims accuracy solutions that enable healthcare clients identify and address claim discrepancies immediately following claim adjudication and before a claim is paid to a healthcare provider; and retrospective claims accuracy solutions that enable health insurers identify and resolve payment inaccuracies after a claim has been paid to a healthcare provider.
Receive News & Ratings for Cotiviti Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cotiviti and related companies with MarketBeat.com's FREE daily email newsletter.